{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:33:49Z","timestamp":1792096429716,"version":"4.4.0"},"reference-count":97,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":285,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013807","name":"Wuhan University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171939"],"award-info":[{"award-number":["82171939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272126"],"award-info":[{"award-number":["82272126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2019QNA40"],"award-info":[{"award-number":["YG2019QNA40"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T14:05:22Z","timestamp":1666015522000},"page":"5713-5728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent computational drug repositioning strategies against SARS-CoV-2"],"prefix":"10.34133","volume":"20","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Human Genetics, Department of Ultrasound, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Zhejiang Provincial Key Laboratory of Genetic & Developmental Disorders, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Department of Ultrasound, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Department of Ultrasound, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"School of Public Health, Undergraduate School of Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Department of Ultrasound, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyano","sequence":"additional","affiliation":[{"name":"M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Deng","sequence":"additional","affiliation":[{"name":"Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Department of Ultrasound, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Zhejiang Provincial Key Laboratory of Genetic & Developmental Disorders, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100127"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19619-7"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2000083"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.014"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2772-0"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Guy RK DiPaola RS Romanelli F et al. Rapid repurposing of drugs for COVID-19 2020;368:829-830.","DOI":"10.1126\/science.abb9332"},{"key":"e_1_3_3_9_2","first-page":"1824","article-title":"Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review","volume":"323","author":"Sanders J.M.","year":"2020","unstructured":"Sanders J.M., Monogue M.L., Jodlowski T.Z. et al: Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020; 323: 1824.","journal-title":"JAMA"},{"key":"e_1_3_3_10_2","first-page":"e00109","article-title":"SARS-CoV-2","volume":"34","author":"Tao K.","year":"2021","unstructured":"Tao K., Tzou P.L., Nouhin J. et al: SARS-CoV-2. Antiviral Therapy 2021; 34: e00109.","journal-title":"Antiviral Therapy"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/bib\/bbaa288","article-title":"A review on drug repurposing applicable to COVID-19","volume":"22","author":"Dotolo S.","year":"2020","unstructured":"Dotolo S., Marabotti A., Facchiano A. et al: A review on drug repurposing applicable to COVID-19. Briefings Bioinf 2020; 22: 726.","journal-title":"Briefings Bioinf"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Dai W Zhang B Jiang X-M et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease 2020;368:1331-1335.","DOI":"10.1126\/science.abb4489"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Jang WD Jeon S Kim S et al. Drugs repurposed for COVID-19 by virtual screening of 6 218 drugs and cell-based assay 2021;118:e2024302118.","DOI":"10.1073\/pnas.2024302118"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.05.005"},{"key":"e_1_3_3_15_2","first-page":"e4279","article-title":"Drug Repositioning for COVID-19","volume":"51","author":"Benavides-Cordoba V.","year":"2020","unstructured":"Benavides-Cordoba V.: Drug Repositioning for COVID-19. Colombia medica (Cali, Colombia) 2020; 51: e4279.","journal-title":"Colombia medica (Cali, Colombia)"},{"key":"e_1_3_3_16_2","first-page":"11455","article-title":"Deep learning applications to combat the dissemination of COVID-19 disease: a review","volume":"24","author":"Alsharif M.H.","year":"2020","unstructured":"Alsharif M.H., Alsharif Y.H., Yahya K. et al: Deep learning applications to combat the dissemination of COVID-19 disease: a review. Eur Rev Med Pharmacol Sci 2020; 24: 11455.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_17_2","first-page":"11977","article-title":"Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2","volume":"24","author":"Alsharif M.H.","year":"2020","unstructured":"Alsharif M.H., Alsharif Y.H., Albreem M.A. et al: Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2. Eur Rev Med Pharmacol Sci 2020; 24: 11977.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_18_2","first-page":"9226","article-title":"Artificial intelligence technology for diagnosing COVID-19 cases: a review of substantial issues","volume":"24","author":"Alsharif M.H.","year":"2020","unstructured":"Alsharif M.H., Alsharif Y.H., Chaudhry S.A. et al: Artificial intelligence technology for diagnosing COVID-19 cases: a review of substantial issues. Eur Rev Med Pharmacol Sci 2020; 24: 9226.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.drudis.2021.10.002","article-title":"Integrating heterogeneous data to facilitate COVID-19 drug repurposing","volume":"27","author":"Prieto Santamar\u00eda L.","year":"2022","unstructured":"Prieto Santamar\u00eda L., D\u00edaz Uzquiano M., Ugarte Carro E. et al: Integrating heterogeneous data to facilitate COVID-19 drug repurposing. Drug Discovery Today 2022; 27: 558.","journal-title":"Drug Discovery Today"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2021.2013852"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09186-x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1195"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","unstructured":"Blanco-Melo D Nilsson-Payant B Liu W-C et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro ex vivo and in vivo systems. 2020.","DOI":"10.1101\/2020.03.24.004655"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.004"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06892"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"Consortium TU","year":"2020","unstructured":"Consortium TU : UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 2020; 49: D480.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa861"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9"},{"key":"e_1_3_3_32_2","unstructured":"Bouhaddou M Memon D Meyer B et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection Cell 2020;182:685-712.e619."},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9403","article-title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms","volume":"370","author":"Gordon D.E.","year":"2020","unstructured":"Gordon D.E., Hiatt J., Bouhaddou M. et al: Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science 2020; 370.","journal-title":"Science"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou Y.","year":"2020","unstructured":"Zhou Y., Hou Y., Shen J. et al: Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discovery 2020; 6: 14.","journal-title":"Cell Discovery"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim S.","year":"2018","unstructured":"Kim S., Chen J., Cheng T. et al: PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 2018; 47: D1102.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr777"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart D.S.","year":"2007","unstructured":"Wishart D.S., Knox C., Guo A.C. et al: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2007; 36: D901.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00559"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","unstructured":"Alexander SP Ball JK Tsoleridis TJIBGtPC. Coronavirus (CoV) proteins (version 2020.4) in the IUPHAR\/BPS Guide to Pharmacology Database 2020;2020.","DOI":"10.2218\/gtopdb\/F1034\/2020.4"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","first-page":"120262","DOI":"10.1109\/ACCESS.2019.2937557","article-title":"Top-N-Targets-Balanced Recommendation Based on Attentional Sequence-to-Sequence Learning","volume":"7","author":"Wang X.","year":"2019","unstructured":"Wang X., Sheng Y., Deng H. et al: Top-N-Targets-Balanced Recommendation Based on Attentional Sequence-to-Sequence Learning. IEEE Access 2019; 7: 120262.","journal-title":"IEEE Access"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine","volume":"110","author":"Whirl-Carrillo M.","year":"2021","unstructured":"Whirl-Carrillo M., Huddart R., Gong L. et al: An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine. Clin Pharmacol Ther 2021; 110: 563.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","first-page":"D684","DOI":"10.1093\/nar\/gkm795","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn M.","year":"2008","unstructured":"Kuhn M., von Mering C., Campillos M. et al: STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 2008; 36: D684.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_43_2","first-page":"D1045","volume":"44","author":"Gilson M.K.","year":"2016","unstructured":"Gilson M.K., Liu T., Baitaluk M. et al: BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology 2016; 44: D1045.","journal-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","unstructured":"Lamb J Crawford ED Peck D et al. The Connectivity Map: using gene-expression signatures to connect small molecules genes and disease 2006;313:1929-1935.","DOI":"10.1126\/science.1132939"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","unstructured":"Stathias V Turner J Koleti A et al. LINCS Data Portal 2.0: next generation access point for perturbation-response signatures 2020;48:D431-D439.","DOI":"10.1093\/nar\/gkz1023"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","unstructured":"Kuhn M Letunic I Jensen LJ et al. The SIDER database of drugs and side effects 2016;44:D1075-D1079.","DOI":"10.1093\/nar\/gkv1075"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","article-title":"The Weber Effect and the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010","volume":"37","author":"Hoffman K.B.","year":"2014","unstructured":"Hoffman K.B., Dimbil M., Erdman C.B. et al: The Weber Effect and the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010. Drug Saf 2014; 37: 283.","journal-title":"Drug Saf"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","unstructured":"Keahey D Goldgar CJTJoPAE. Evidence-based medicine resources for physician assistant faculty: DynaMed 2008;19:43-46.","DOI":"10.1097\/01367895-200819010-00010"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","unstructured":"Miller G Britt HJIjob-mc. A new drug classification for computer systems: the ATC extension code 1995;40:121-124.","DOI":"10.1016\/0020-7101(95)01135-2"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","unstructured":"Degtyarenko K De Matos P Ennis M et al. ChEBI: a database and ontology for chemical entities of biological interest 2007;36:D344-D350.","DOI":"10.1093\/nar\/gkm791"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-8955-3_6","article-title":"Network-Based Drug Repositioning: Approaches, Resources, and Research Directions","volume":"1903","author":"Alaimo S.","year":"2019","unstructured":"Alaimo S. and Pulvirenti A.: Network-Based Drug Repositioning: Approaches, Resources, and Research Directions. Methods Mol Biol 2019; 1903: 97.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1614"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"i813","DOI":"10.1093\/bioinformatics\/btaa813","article-title":"FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2","volume":"36","author":"Renz A.","year":"2020","unstructured":"Renz A., Widerspick L. and Dr\u00e4ger A.: FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2. Bioinformatics 2020; 36: i813.","journal-title":"Bioinformatics"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30192-8"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","unstructured":"Subramanian A Tamayo P Mootha VK et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles 2005;102:15545-15550.","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv313"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","unstructured":"Xie Z Bailey A Kuleshov MV et al. Gene Set Knowledge Discovery with Enrichr 2021;1:e90.","DOI":"10.1002\/cpz1.90"},{"key":"e_1_3_3_60_2","doi-asserted-by":"crossref","unstructured":"Mahmud SMH Al-Mustanjid M Akter F et al. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients Briefings in Bioinformatics 2021;22:bbab115.","DOI":"10.1093\/bib\/bbab115"},{"key":"e_1_3_3_61_2","unstructured":"Subramanian A Narayan R Corsello SM et al. A Next Generation Connectivity Map: L1000 Platform and the First 1 000 000 Profiles Cell 2017;171:1437-1452.e1417."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-020-00285-9"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.360221211"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci00057a005"},{"key":"e_1_3_3_66_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13321-015-0068-4","article-title":"InChI, the IUPAC international chemical identifier","volume":"7","author":"Heller S.","year":"2015","unstructured":"Heller S., McNaught A., Pletnev I. et al: InChI, the IUPAC international chemical identifier. J Cheminformat 2015; 7: 23.","journal-title":"J Cheminformat"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2020.05.001"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci100050t"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2014.08.005"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.03.025"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117652"},{"key":"e_1_3_3_72_2","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/bioinformatics\/btaa224","article-title":"Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus","volume":"36","author":"Liu S.","year":"2020","unstructured":"Liu S., Zheng Q. and Wang Z.: Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus. Bioinformatics 2020; 36: 3295.","journal-title":"Bioinformatics"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.08.016"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2601-5"},{"key":"e_1_3_3_76_2","first-page":"176","article-title":"Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple","volume":"14","author":"Yu P.-C.","year":"2022","unstructured":"Yu P.-C., Huang C.-H., Kuo C.-J. et al: Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple. Targets 2022; 14: 176.","journal-title":"Targets"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","unstructured":"Daniloski Z Jordan TX Wessels HH et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells Cell 2021;184:92-105.e116.","DOI":"10.1016\/j.cell.2020.10.030"},{"key":"e_1_3_3_78_2","doi-asserted-by":"crossref","unstructured":"Wei J Alfajaro MM DeWeirdt PC et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection Cell 2021;184:76-91.e13.","DOI":"10.1016\/j.cell.2020.10.028"},{"key":"e_1_3_3_79_2","article-title":"Comparison of viral RNA\u2013host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2","author":"Zhang S.","year":"2021","unstructured":"Zhang S., Huang W., Ren L. et al: Comparison of viral RNA\u2013host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2. Cell Res 2021; .","journal-title":"Cell Res"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1094"},{"key":"e_1_3_3_81_2","doi-asserted-by":"crossref","first-page":"D581","DOI":"10.1093\/nar\/gky1037","article-title":"IID 2018 update: context-specific physical protein\u2013protein interactions in human, model organisms and domesticated species","volume":"47","author":"Kotlyar M.","year":"2018","unstructured":"Kotlyar M., Pastrello C., Malik Z. et al: IID 2018 update: context-specific physical protein\u2013protein interactions in human, model organisms and domesticated species. Nucleic Acids Res 2018; 47: D581.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05116-5"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002503"},{"key":"e_1_3_3_84_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-8955-3_6","volume-title":"Computational Methods for Drug Repurposing","author":"Alaimo S.","year":"2019","unstructured":"Alaimo S. and Pulvirenti A.: Network-Based Drug Repositioning: Approaches, Resources, and Research Directions. In: Computational Methods for Drug Repurposing. Edited by Q. Vanhaelen. Springer, New York: New York, NY 2019: 97."},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17189-2"},{"key":"e_1_3_3_86_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41392-021-00568-6","article-title":"An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19","volume":"6","author":"Ge Y.","year":"2021","unstructured":"Ge Y., Tian T., Huang S. et al: An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduction and Targeted Therapy 2021; 6: 165.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00316"},{"key":"e_1_3_3_88_2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab114","article-title":"Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19","volume":"22","author":"Tomazou M.","year":"2021","unstructured":"Tomazou M., Bourdakou M.M., Minadakis G. et al: Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Briefings Bioinf 2021; 22.","journal-title":"Briefings Bioinf"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000970"},{"key":"e_1_3_3_90_2","doi-asserted-by":"crossref","unstructured":"Jin W Stokes JM Eastman RT et al. Deep learning identifies synergistic drug combinations for treating COVID-19 2021;118:e2105070118.","DOI":"10.1073\/pnas.2105070118"},{"key":"e_1_3_3_91_2","article-title":"COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach","author":"Cheng F.","year":"2020","unstructured":"Cheng F., Rao S. and Mehra R.: COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach. Cleve Clin J Med 2020; .","journal-title":"Cleve Clin J Med"},{"key":"e_1_3_3_92_2","unstructured":"Kandeel M Mohamed MEM Abd El-Lateef HM et al. Omicron variant genome evolution and phylogenetics;n\/a."},{"key":"e_1_3_3_93_2","first-page":"eabn7760","article-title":"SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex","author":"Mannar D.","year":"2022","unstructured":"Mannar D., Saville J.W., Zhu X. et al: SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science 2022:; : eabn7760.","journal-title":"Science"},{"key":"e_1_3_3_94_2","unstructured":"SARS-CoV-2 Alpha variant. https:\/\/en.wikipedia.org\/wiki\/SARS-CoV-2_Alpha_variant."},{"key":"e_1_3_3_95_2","unstructured":"SARS-CoV-2 Beta variant. https:\/\/en.wikipedia.org\/wiki\/SARS-CoV-2_Beta_variant."},{"key":"e_1_3_3_96_2","unstructured":"Callaway E. Remember Beta? New data reveal variant\u2019s deadly powers."},{"key":"e_1_3_3_97_2","unstructured":"Mille K. Omicron vs. Delta COVID-19 Variants: Do We Need Another Vaccine? https:\/\/www.prevention.com\/health\/a38400888\/omicron-vs-delta-covid-19-variant-comparison\/."},{"key":"e_1_3_3_98_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","author":"Cao Y.","year":"2021","unstructured":"Cao Y., Wang J., Jian F. et al: Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 2021; .","journal-title":"Nature"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022004640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022004640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.10.017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T15:47:14Z","timestamp":1779032834000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.10.017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":97,"alternative-id":["10.1016\/j.csbj.2022.10.017"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.10.017","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent computational drug repositioning strategies against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}